Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 7555

In scope icon N/A E
QID 7555 (Type "7555" in App Search)
A 65-year-old woman has a bone mineral density t-score of -2.0. She has no identifiable secondary cause of bone loss. In addition to calcium and vitamin D supplementation, this patient should be considered for

calcitonin.

0%

0/0

hormone replacement therapy.

0%

0/0

teriparatide.

0%

0/0

bisphosphonate therapy.

0%

0/0

observation.

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

A patient with a bone mineral density t-score of between -1.0 and -2.5 should be considered for osteoporosis prevention therapy. This would consist of calcium (1,200 to 1,500 mg daily), vitamin D (800 to 1000 IU daily), and a bisphosphonate. Calcitonin and teriparatide are used to treat established osteoporosis (t-score of -2.5 or lower). Observation is not recommended with a t-score of less than -1.0. Hormone replacement therapy is associated with an increased risk of cardiovascular disease and breast cancer.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

1.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(1)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options